MaxCyte, Inc. (MXCT) stock
MXCTNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3065% below fair value
$1.19+0.09 (+8.18%)
Close on Nov 12, 2026Market cap $122.82MP/E –Yield –
MaxCyte market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
MaxCyte's market cap was $116.75M on Nov 11, 2026, against $187.69M a year earlier. Over the last 5 years it ranged from $75.02M to $1.02B, with a median of $419.85M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $116.75M | -29.4% |
| 2025 | Dec 31, 2025 | $165.30M | -62.3% |
| 2024 | Dec 31, 2024 | $438.05M | -10.0% |
| 2023 | Dec 29, 2023 | $486.68M | -12.5% |
| 2022 | Dec 30, 2022 | $556.40M | -45.6% |
| 2021 | Dec 31, 2021 | $1.02B | – |
See a number that looks wrong?